ebook Munafa Stock Market Course + Intraday & FNO calls  

       

RARX announcements Ra Pharmaceuticals, Inc. announcements and dividends declared NASDAQ

Ra Pharmaceuticals, Inc. Complete list of announcements declared & dividend announcements by Ra Pharmaceuticals, Inc. RARX

Ra Pharmaceuticals, Inc. RARX listed on NASDAQ and deals in Health Care Major Pharmaceuticals

Announcements and dividends declared by Ra Pharmaceuticals, Inc. RARX

: Cannabis pharma Mira Pharmaceuticals ups IPO size
Cannabis-focused Mira Pharmaceuticals Inc. increased the size of its initial public offering to 1.2 million shares and set the offering price at a share, according to a filing late Friday. Mira earlier this month had said it would offer 1 million shares
Announcement as on 21 July 2023

: Mira Pharmaceuticals files for IPO in busy week for deals
Cannabis-focused Mira Pharmaceuticals Inc. on Thursday filed for an initial public offering, the latest in what has been a busy week for IPOs. The company, an early pre-clinical stage pharma developer, said it is developing a “new molecular synthetic THC
Announcement as on 29 June 2023

Deutsche Reiterates Dechra Pharmaceuticals (LSE:DPH) Outperform Recommendation
Fintel reports that on May 25, 2023, Deutsche reiterated coverage of Dechra Pharmaceuticals (LSE:DPH) with a Outperform recommendation.
Announcement as on 28 May 2023

Deciphera Pharmaceuticals, Inc. (DCPH) Soars 10.3%: Is Further Upside Left in the Stock?
Deciphera Pharmaceuticals, Inc. (DCPH) shares soared 10.3% in the last trading session to close at . The move was backed by solid volume with far more shares changing hands than in a normal session. This compares to the stock's 10.4% loss over the past
Announcement as on 14 March 2023

Idera Pharmaceuticals stock plunges after disappointing trial results, prompting analyst downgrade
Shares of Idera Pharmaceuticals Inc. plummeted 63.3% in active trading to pace all premarket decliners, after the immunotherapy company said the ILLUMINATE-301 pivotal registration trial of its treatment of patients with anti-PD-1 refractory advanced mela
Announcement as on 19 March 2021

Announcements by Ra Pharmaceuticals, Inc. first page | Next page |

RARX Ra Pharmaceuticals, Inc. current price & indicator signals

Moving Averages for Ra Pharmaceuticals, Inc.

  • 5Day Average: 47.44
  • 12Day Average: 46.02
  • 20Day Average: 46.03
  • 50Day Average: 46.43
  • 100Day Average: 46.66
  • 150Day Average: 42.54
  • 200Day Average: 39.5

RARX Indicators & signals

Indicator MACD (12,26,9)

46.73, 46.4, -0.02
Indicator MACD is in positive zone

Indicator ADX (14)

14.89, 14.18, 19.15
Indicator ADX is indicating that momentum is weak.
Momentum is towards selling.

Indicator RSI (14)

Current RSI is: 54
Indicator RSI is indicating buying momentum and stock might rise.

Recent prices of RARX Ra Pharmaceuticals, Inc. are as follows: Daily volume is divided by 10 day averaged volume

Date Close Range Change % Volume
01 Wed Apr 2020 48.00 47.98 to 48.01 -0.02% 1.68 times
31 Tue Mar 2020 48.01 47.96 to 48.02 1.42% 3.12 times
30 Mon Mar 2020 47.34 46.91 to 47.50 0.94% 0.53 times
27 Fri Mar 2020 46.90 46.78 to 47.36 -0.13% 0.53 times
26 Thu Mar 2020 46.96 46.34 to 47.74 -1.26% 0.71 times
25 Wed Mar 2020 47.56 44.50 to 47.77 3.5% 2.42 times
24 Tue Mar 2020 45.95 43.78 to 46.20 1.3% 0.47 times
23 Mon Mar 2020 45.36 44.63 to 45.99 -0.74% 0.39 times
20 Fri Mar 2020 45.70 44.31 to 46.20 1.08% 0.49 times
19 Thu Mar 2020 45.21 40.49 to 45.74 11.6% 0.76 times
18 Wed Mar 2020 40.51 40.30 to 44.96 -9.47% 0.58 times
17 Tue Mar 2020 44.75 41.88 to 45.55 1.22% 0.79 times

Videos related to: RARX announcements Ra Pharmaceuticals, Inc. announcements and dividends declared NASDAQ

Hindi Video Correct Way Of Fundamental Analysis Using EPS And PE - MunafaSutra

Hindi Video What Is Needed To Succeed In Stock Markets

RARX announcements Ra Pharmaceuticals, Inc. announcements and dividends declared NASDAQ

 

Back to top